Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer	Ovarian High Grade Serous Adenocarcinoma; Platinum-Resistant Ovarian Carcinoma	Recruiting	Phase 2	2026-10-01		NCT05998135

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Emory University	393
National Cancer Institute (NCI)	3015

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Emory University Hospital/Winship Cancer Institute	Atlanta	United States	299

Clinical trials